PALLOTTA, MARIA TERESA
 Distribuzione geografica
Continente #
NA - Nord America 3.534
EU - Europa 2.436
AS - Asia 2.295
SA - Sud America 335
Continente sconosciuto - Info sul continente non disponibili 287
AF - Africa 56
OC - Oceania 3
Totale 8.946
Nazione #
US - Stati Uniti d'America 3.360
SG - Singapore 990
IT - Italia 793
CN - Cina 362
HK - Hong Kong 307
VN - Vietnam 292
IE - Irlanda 282
BR - Brasile 235
FR - Francia 225
RU - Federazione Russa 218
DE - Germania 204
RO - Romania 179
FI - Finlandia 93
GB - Regno Unito 91
UA - Ucraina 91
CA - Canada 88
IN - India 66
SE - Svezia 66
KR - Corea 45
BE - Belgio 41
AR - Argentina 39
BD - Bangladesh 36
CZ - Repubblica Ceca 34
MX - Messico 29
NL - Olanda 26
TR - Turchia 26
JP - Giappone 25
CO - Colombia 20
IQ - Iraq 19
ID - Indonesia 18
PL - Polonia 17
VE - Venezuela 17
PK - Pakistan 16
ZA - Sudafrica 15
AT - Austria 14
CH - Svizzera 14
ES - Italia 14
NI - Nicaragua 12
EC - Ecuador 11
PH - Filippine 10
GT - Guatemala 9
CW - ???statistics.table.value.countryCode.CW??? 8
IL - Israele 8
LT - Lituania 8
SA - Arabia Saudita 8
UZ - Uzbekistan 8
AZ - Azerbaigian 7
CI - Costa d'Avorio 7
GR - Grecia 7
AE - Emirati Arabi Uniti 6
JM - Giamaica 6
PR - Porto Rico 6
TN - Tunisia 6
CR - Costa Rica 5
JO - Giordania 5
LB - Libano 5
SC - Seychelles 5
CL - Cile 4
EE - Estonia 4
ET - Etiopia 4
EU - Europa 4
HN - Honduras 4
IR - Iran 4
MA - Marocco 4
SV - El Salvador 4
TH - Thailandia 4
KE - Kenya 3
KW - Kuwait 3
KZ - Kazakistan 3
MK - Macedonia 3
NP - Nepal 3
OM - Oman 3
PE - Perù 3
PS - Palestinian Territory 3
TT - Trinidad e Tobago 3
AO - Angola 2
BH - Bahrain 2
BO - Bolivia 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
EG - Egitto 2
HU - Ungheria 2
MT - Malta 2
MY - Malesia 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
PY - Paraguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AM - Armenia 1
BT - Bhutan 1
BY - Bielorussia 1
BZ - Belize 1
CG - Congo 1
CU - Cuba 1
GD - Grenada 1
GE - Georgia 1
GP - Guadalupe 1
HR - Croazia 1
Totale 8.655
Città #
Singapore 751
Perugia 406
Ashburn 334
Chandler 329
Hong Kong 304
San Jose 303
Dublin 282
Dong Ket 167
Bucharest 155
San Mateo 140
Santa Clara 135
Boardman 123
Beijing 115
Council Bluffs 97
Munich 93
Los Angeles 83
Moscow 81
Redmond 77
Wilmington 66
Medford 58
Princeton 58
Lauterbourg 56
Altamura 55
Ann Arbor 54
Dallas 45
Seoul 44
New York 43
Lawrence 42
Brussels 41
Andover 39
Ho Chi Minh City 36
Jacksonville 35
The Dalles 33
Chicago 28
Des Moines 27
Pisa 26
Helsinki 25
Rome 24
Turku 23
Hanoi 22
Chennai 21
Phoenix 21
Tokyo 21
Falls Church 20
Montreal 20
Atlanta 19
Toronto 19
Dearborn 18
Denver 18
Olomouc 18
São Paulo 18
Orem 17
Piscataway 17
Redwood City 17
Milan 16
Saint Petersburg 16
Brno 15
Columbus 15
West Jordan 14
Frankfurt am Main 13
Fremont 13
Johannesburg 13
North Bergen 13
Nuremberg 13
Warsaw 13
Norwalk 12
San Paolo di Civitate 12
Brooklyn 11
Chiajna 11
Enfield 11
Guangzhou 11
Izmir 11
London 11
Managua 11
Poplar 11
Stockholm 11
Haiphong 10
Lappeenranta 10
Manchester 10
Măgurele 10
Terni 10
Amsterdam 9
Bologna 9
Boston 9
Hefei 9
Houston 9
San Francisco 9
Woodbridge 9
Da Nang 8
Mexico City 8
Mumbai 8
Nanjing 8
Querétaro 8
San Diego 8
Willemstad 8
Abidjan 7
Buenos Aires 7
Florence 7
Rio de Janeiro 7
Riyadh 7
Totale 5.600
Nome #
Stem cells from human amniotic fluid exert immunoregulatory function via secreted indoleamine 2,3-dioxygenase1 233
Class IA PI3Ks regulate subcellular and functional dynamics of IDO1 220
A Relay Pathway between Arginine and Tryptophan Metabolism Confers Immunosuppressive Properties on Dendritic Cells 215
Allosteric modulation of metabotropic glutamate receptor 4 activates IDO1-dependent, immunoregulatory signaling in dendritic cells 212
Amino-acid sensing and degrading pathways in immune regulation 205
Aryl hydrocarbon receptor control of a disease tolerance defence pathway. 200
Engagement of Nuclear Coactivator 7 by 3-Hydroxyanthranilic Acid Enhances Activation of Aryl Hydrocarbon Receptor in Immunoregulatory Dendritic Cells 197
Advances in indoleamine 2,3-dioxygenase 1 medicinal chemistry 191
Distinct roles of immunoreceptor tyrosine-based motifs in immunosuppressive indoleamine 2,3-dioxygenase 1. 190
Amino acid metabolism as drug target in autoimmune diseases 186
Identification of a 2-propanol analogue modulating the non-enzymatic function of indoleamine 2,3-dioxygenase 1 180
Positive allosteric modulation of indoleamine 2,3-dioxygenase 1 restrains neuroinflammation 179
87P - Towards the identification of the mechanism of action of antitumor 1-methyl-D-tryptophan 167
88P - Relationship between functions and intracellular localization of the immune checkpoint target indoleamine 2, 3-dioxygenase 1 158
Cutting edge: Autocrine TGF-beta sustains default tolerogenesis by IDO-competent dendritic cells. 157
LPS-conditioned dendritic cells confer endotoxin tolerance contingent on tryptophan catabolism 153
Dendritic cells expressing ectopic IL-35Ig induce IDO-related tolerance in vivo. 149
Deficiency of immunoregulatory indoleamine 2,3-dioxygenase 1 in juvenile diabetes 149
Epacadostat stabilizes the apo-form of IDO1 and signals a pro-tumorigenic pathway in human ovarian cancer cells 146
The TGF-β/IDO axis in infectious tolerance. 145
Aryl hydrocarbon Receptor and RelB control long term expression of Indoleamine 2,3-dioxygenase-1 in endotoxin tolerance 145
Pharmacologic Induction of Endotoxin Tolerance in Dendritic Cells by L-Kynurenine 144
Critical Assessment of a Structure-Based Screening Campaign for IDO1 Inhibitors: Tips and Pitfalls 142
The [1,2,4]Triazolo[4,3-a]pyridine as a New Player in the Field of IDO1 Catalytic Holo-Inhibitors 141
Discovery of Highly Potent Benzimidazole Derivatives as Indoleamine 2,3-Dioxygenase-1 (IDO1) Inhibitors: From Structure-Based Virtual Screening to in Vivo Pharmacodynamic Activity 139
Novel mutations in the WFS1 gene are associated with Wolfram syndrome and systemic inflammation 136
WESTERN BLOT IDENTIFICATION OF NPM1 LEUKEMIC MUTANTS IN CYTOLOGICAL AML SAMPLES: A POWERFUL DIAGNOSTIC TECHNIQUE 135
AhR-Mediated, Non-Genomic Modulation of IDO1 Function 132
Forced IDO1 expression in dendritic cells restores immunoregulatory signalling in autoimmune diabetes 129
Different partners, opposite outcomes: A New Perspective of the Immunobiology of Indoleamine 2,3-Dioxygenase 128
Amino acid metabolism in rheumatoid arthritis: Friend or foe? 125
Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells 123
Effect of Probiotic Administration on Serum Tryptophan Metabolites in Pediatric Type 1 Diabetes Patients 123
The catalytic inhibitor epacadostat can affect the non-enzymatic function of IDO1 122
Effects of probiotic administration on immune responses of children and adolescents with type 1 diabetes to a quadrivalent inactivated influenza vaccine 122
Pathogenetic Interplay Between IL-6 and Tryptophan Metabolism in an Experimental Model of Obesity 121
Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosis 118
Unconventional Pathways of Protein Secretion: Mammals vs. Plants 117
Immunohistochemistry predicts nucleophosmin (NPM) mutations in acute myeloid leukemia 117
Extracellular Vesicles in Aging: An Emerging Hallmark? 113
Immunosuppression via tryptophan catabolism: the role of kynurenine pathway enzymes. 110
The signaling function of IDO1 incites the malignant progression of mouse B16 melanoma 109
High doses of CpG oligodeoxynucleotides stimulate a tolerogenic TLR9-TRIF pathway. 109
Reinstalling immune regulatory tryptophan catabolism in juvenile diabetes via interleukin 6 receptor blockade 107
Human Indoleamine 2,3-dioxygenase 1 (IDO1) Expressed in Plant Cells Induces Kynurenine Production 106
Wolfram syndrome, a rare neurodegenerative disease: From pathogenesis to future treatment perspectives 105
Membrane Localization and Phosphorylation of Indoleamine 2,3-Dioxygenase 2 (IDO2) in A549 Human Lung Adenocarcinoma Cells: First Steps in Exploring Its Signaling Function 101
CTLA-4-immunoglobulin and indoleamine 2,3 dioxygenase in dominant tolerance. 99
Ectopic expression of IL-35Ig by dendritic cells induces IDO-related tolerance in vivo 99
Indoleamine 2,3-dioxygenase 1 (IDO1): an up-to-date overview of an eclectic immunoregulatory enzyme 98
Sensing of an HIV-1-Derived Single-Stranded RNA-Oligonucleotide Induces Arginase 1-Mediated Tolerance 96
IDO1 and TGF-β mediate protective effects of IFN-α in antigen-induced arthritis 96
Endotoxin tolerance as a novel defense strategy in infectious diseases: the role of tryptophan catabolism 95
Identification of a Compound Inhibiting Both the Enzymatic and Nonenzymatic Functions of Indoleamine 2,3-Dioxygenase 1 95
Proteasomal Degradation of Indoleamine 2,3-Dioxygenase in CD8 Dendritic Cells is Mediated by Suppressor of Cytokine Signaling 3 (SOCS3). 91
The Proteasome Inhibitor Bortezomib Controls Indoleamine 2,3-Dioxygenase 1 Breakdown and Restores Immune Regulation in Autoimmune Diabetes. 91
SOCS3 drives proteasomal degradation of indoleamine 2,3-dioxygenase (IDO) and antagonizes IDO-dependent tolerogenesis 90
FGF2 and IL-1β - explorers of unconventional secretory pathways at a glance 90
Author Correction: Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosis 89
Topical application of soluble CD83 induces IDO-mediated immune modulation, increases foxp3+ T cells, and prolongs allogeneic corneal graft survival 85
Unconventional Transport Routes of Soluble and Membrane Proteins and Their Role in Developmental Biology 85
Publisher Correction: Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosis 79
PROTEASOME INHIBITION IN pDCs CONFERS AN IDO-DEPENDENT IMMUNOREGULATORY PHENOTYPE 72
Moonlighting Proteins Are Important Players in Cancer Immunology 72
Immune system to brain signaling and vice versa: The role of tryptophan and glutamate 70
GLP-1 receptor agonists as promising disease-modifying agents in WFS1 spectrum disorder 66
Vedere per credere: utilizzo della microscopia per lo studio dell’immunologia 65
Western blot identification of NPM1 leukemic mutants in cytological AML samples: A powerful diagnostic technique 62
Adverse pro-tumorigenic effects of IDO1 catalytic inhibitors mediated by the non-enzymatic function of IDO1 in tumor cells 60
IDO-TARGETING INTERVENTION IN AUTOIMMUNE DIABETES BY PROTEASOME INHIBITION 56
Indoleamine 2,3 dioxygnenase: as an inducer and amplifier of regulatory T cell functions. 55
Gallic acid released by a layered double hydroxide-coated scaffold of hydroxyapatite and β-tricalcium phosphate inhibits the osteoclast formation In Vitro 39
Totale 8.946
Categoria #
all - tutte 36.818
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.818


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022714 0 0 0 0 28 17 6 153 101 116 94 199
2022/20231.122 61 190 16 84 105 99 2 64 388 14 87 12
2023/2024607 27 69 21 13 8 11 158 18 42 35 65 140
2024/20251.301 21 98 57 107 124 87 104 141 212 71 171 108
2025/20262.905 166 181 168 364 389 305 474 189 297 235 82 55
2026/2027868 71 100 190 435 72 0 0 0 0 0 0 0
Totale 8.946